Literature DB >> 9233415

Obsessive compulsive disorder and the right hemisphere: topographic analysis of lesions after anterior capsulotomy performed with thermocoagulation.

B Lippitz1, P Mindus, B A Meyerson, L Kihlström, C Lindquist.   

Abstract

Considerable but uncontrolled evidence suggests that stereotactic capsulotomy by means of thermolesions may provide symptomatic relief for patients with otherwise therapy refractory "malignant" obsessive compulsive disorder (OCD). Unlike in other functional stereotactic interventions, target localization for capsulotomy is based upon anatomical definition only. Few systematic attempts have been made to correlate the site and size of the capsular lesions with postoperative clinical outcome. Between 1976 and 1989 bilateral thermo-capsulotomy (TC) was performed in 22 OCD patients. In 19 patients complete quantitative pre- and postoperative psychiatric rating of OCD symptoms and long-term postoperative MRI studies were available. Cohorts of patients fulfilling criteria for good or poor outcome were contrasted, cases with intermediate treatment effect being excluded. Median postoperative MRI follow-up was 8.4 years (2.4-20.3 y). 9/19 patients fulfilled criteria for good postoperative outcome. In these patients all lesion sites overlapped covering a small area within the right anterior limb of the internal capsule. Lesions within the group of patients with poor outcome (n = 5) were located elsewhere, mostly further anterior in the internal capsule. Differences of lesion overlap between the two outcome groups were significant for the right side (Fisher's Exact Test: p < 0.005). Common topographic features of lesion sites within the right internal capsule were identified in OCD patients responding favourably to capsulotomy.

Entities:  

Mesh:

Year:  1997        PMID: 9233415     DOI: 10.1007/978-3-7091-6513-3_11

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  8 in total

1.  Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming.

Authors:  Michael S Okun; Giselle Mann; Kelly D Foote; Nathan A Shapira; Dawn Bowers; Utaka Springer; William Knight; Pamela Martin; Wayne K Goodman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

2.  Greater regional cortical gray matter thickness in obsessive-compulsive disorder.

Authors:  Veena M Narayan; Katherine L Narr; Owen R Phillips; Paul M Thompson; Arthur W Toga; Philip R Szeszko
Journal:  Neuroreport       Date:  2008-10-08       Impact factor: 1.837

Review 3.  Central neuromodulation for refractory pain.

Authors:  Nina Z Moore; Scott F Lempka; Andre Machado
Journal:  Neurosurg Clin N Am       Date:  2013-10-10       Impact factor: 2.509

4.  Radiofrequency Lesioning for Movement and Psychiatric Disorders-Experience of 107 Cases.

Authors:  Paresh K Doshi
Journal:  Front Hum Neurosci       Date:  2021-06-14       Impact factor: 3.169

Review 5.  The Evolution of Modern Ablative Surgery for the Treatment of Obsessive-Compulsive and Major Depression Disorders.

Authors:  Martina Laetitia Mustroph; G Rees Cosgrove; Ziv M Williams
Journal:  Front Integr Neurosci       Date:  2022-04-06

6.  Tractography Activation Patterns in Dorsolateral Prefrontal Cortex Suggest Better Clinical Responses in OCD DBS.

Authors:  Christian J Hartmann; J Luis Lujan; Ashutosh Chaturvedi; Wayne K Goodman; Michael S Okun; Cameron C McIntyre; Ihtsham U Haq
Journal:  Front Neurosci       Date:  2016-01-19       Impact factor: 4.677

7.  The Potential Usefulness of Magnetic Resonance Guided Focused Ultrasound for Obsessive Compulsive Disorders.

Authors:  Hyun Ho Jung; Won Seok Chang; Se Joo Kim; Chan-Hyung Kim; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2018-04-10

8.  Examining cognitive change in magnetic resonance-guided focused ultrasound capsulotomy for psychiatric illness.

Authors:  Benjamin Davidson; Clement Hamani; Ying Meng; Anusha Baskaran; Sachie Sharma; Agessandro Abrahao; Margaret Anne Richter; Anthony Levitt; Peter Giacobbe; Nir Lipsman; Jennifer S Rabin
Journal:  Transl Psychiatry       Date:  2020-11-11       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.